Cargando…

Switch to once or twice daily unboosted atazanavir in a cohort of stable HIV patients: strong differences in drug exposure and virological outcome

Detalles Bibliográficos
Autores principales: Baudry, T, Boibieux, A, Gagnieu, MC, Cotte, L, Livrozet, JM, Miahles, P, Makhloufi, D, Chidiac, C, Peyramond, D, Ferry, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113050/
http://dx.doi.org/10.1186/1758-2652-13-S4-P47
_version_ 1782205876647493632
author Baudry, T
Boibieux, A
Gagnieu, MC
Cotte, L
Livrozet, JM
Miahles, P
Makhloufi, D
Chidiac, C
Peyramond, D
Ferry, T
author_facet Baudry, T
Boibieux, A
Gagnieu, MC
Cotte, L
Livrozet, JM
Miahles, P
Makhloufi, D
Chidiac, C
Peyramond, D
Ferry, T
author_sort Baudry, T
collection PubMed
description
format Online
Article
Text
id pubmed-3113050
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31130502011-06-13 Switch to once or twice daily unboosted atazanavir in a cohort of stable HIV patients: strong differences in drug exposure and virological outcome Baudry, T Boibieux, A Gagnieu, MC Cotte, L Livrozet, JM Miahles, P Makhloufi, D Chidiac, C Peyramond, D Ferry, T J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113050/ http://dx.doi.org/10.1186/1758-2652-13-S4-P47 Text en Copyright ©2010 Baudry et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Baudry, T
Boibieux, A
Gagnieu, MC
Cotte, L
Livrozet, JM
Miahles, P
Makhloufi, D
Chidiac, C
Peyramond, D
Ferry, T
Switch to once or twice daily unboosted atazanavir in a cohort of stable HIV patients: strong differences in drug exposure and virological outcome
title Switch to once or twice daily unboosted atazanavir in a cohort of stable HIV patients: strong differences in drug exposure and virological outcome
title_full Switch to once or twice daily unboosted atazanavir in a cohort of stable HIV patients: strong differences in drug exposure and virological outcome
title_fullStr Switch to once or twice daily unboosted atazanavir in a cohort of stable HIV patients: strong differences in drug exposure and virological outcome
title_full_unstemmed Switch to once or twice daily unboosted atazanavir in a cohort of stable HIV patients: strong differences in drug exposure and virological outcome
title_short Switch to once or twice daily unboosted atazanavir in a cohort of stable HIV patients: strong differences in drug exposure and virological outcome
title_sort switch to once or twice daily unboosted atazanavir in a cohort of stable hiv patients: strong differences in drug exposure and virological outcome
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113050/
http://dx.doi.org/10.1186/1758-2652-13-S4-P47
work_keys_str_mv AT baudryt switchtoonceortwicedailyunboostedatazanavirinacohortofstablehivpatientsstrongdifferencesindrugexposureandvirologicaloutcome
AT boibieuxa switchtoonceortwicedailyunboostedatazanavirinacohortofstablehivpatientsstrongdifferencesindrugexposureandvirologicaloutcome
AT gagnieumc switchtoonceortwicedailyunboostedatazanavirinacohortofstablehivpatientsstrongdifferencesindrugexposureandvirologicaloutcome
AT cottel switchtoonceortwicedailyunboostedatazanavirinacohortofstablehivpatientsstrongdifferencesindrugexposureandvirologicaloutcome
AT livrozetjm switchtoonceortwicedailyunboostedatazanavirinacohortofstablehivpatientsstrongdifferencesindrugexposureandvirologicaloutcome
AT miahlesp switchtoonceortwicedailyunboostedatazanavirinacohortofstablehivpatientsstrongdifferencesindrugexposureandvirologicaloutcome
AT makhloufid switchtoonceortwicedailyunboostedatazanavirinacohortofstablehivpatientsstrongdifferencesindrugexposureandvirologicaloutcome
AT chidiacc switchtoonceortwicedailyunboostedatazanavirinacohortofstablehivpatientsstrongdifferencesindrugexposureandvirologicaloutcome
AT peyramondd switchtoonceortwicedailyunboostedatazanavirinacohortofstablehivpatientsstrongdifferencesindrugexposureandvirologicaloutcome
AT ferryt switchtoonceortwicedailyunboostedatazanavirinacohortofstablehivpatientsstrongdifferencesindrugexposureandvirologicaloutcome